DEPODUR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Depodur, and when can generic versions of Depodur launch?
Depodur is a drug marketed by Pacira Pharms Inc and is included in one NDA.
The generic ingredient in DEPODUR is morphine sulfate. There are twenty-three drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depodur
A generic version of DEPODUR was approved as morphine sulfate by HOSPIRA on September 30th, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEPODUR?
- What are the global sales for DEPODUR?
- What is Average Wholesale Price for DEPODUR?
Summary for DEPODUR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 11 |
| Patent Applications: | 3,870 |
| DailyMed Link: | DEPODUR at DailyMed |
Recent Clinical Trials for DEPODUR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Columbia University | Phase 4 |
| Washington University School of Medicine | N/A |
| Wake Forest University | Phase 4 |
US Patents and Regulatory Information for DEPODUR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPODUR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEPODUR
See the table below for patents covering DEPODUR around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Israel | 85509 | MULTIVESICULAR LIPOSOMES HAVING A BIOLOGICALLY ACTIVE SUBSTANCE ENCAPSULATED THEREIN IN THE PRESENCE OF A HYDROCHLORIDE AND THEIR PRODUCTION | ⤷ Start Trial |
| Canada | 2226870 | ADMINISTRATION EPIDURALE DE COMPOSES THERAPEUTIQUES AVEC UNEVITESSE FAIBLE DE LIBERATION (EPIDURAL ADMINISTRATION OF THERAPEUTIC COMPOUNDS WITH SUSTAINED RATE OF RELEASE) | ⤷ Start Trial |
| Germany | 19810074 | ⤷ Start Trial | |
| China | 1195286 | ⤷ Start Trial | |
| Japan | 2010031030 | EPIDURAL ADMINISTRATION OF THERAPEUTIC COMPOUNDS WITH SUSTAINED RATE OF RELEASE | ⤷ Start Trial |
| Finland | 95439 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for DEPODUR
More… ↓
